Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: May 25, 2023 Report Code: GDME1542EPD-ST

Select Item

Cortical Stimulators Pipeline Market Report Overview

The cortical stimulator is a medical device. It is used to revive neural activity in the nervous system of critical patients by delivering an electrical shock using leads and electrode arrays implanted on the surface of the brain to induce brain activity. DBS devices send electrical stimulation through surgically-implanted electrodes to specific targets in the brain.

The cortical stimulators pipeline market research report provides comprehensive information about the cortical stimulators pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       India

·       Japan

·       Taiwan
Key Regulatory Paths ·       PMA

·       510(k)

·       CE

·       BOPA

·       TGA

·       ICAC

·       NIFDS
Leading Companies ·       ab medica spa

·       Aleva Neurotherapeutics SA

·       Cadence Neuroscience Inc

·       Catalan Institute of Nanoscience and Nanotechnology

·       Cerephex Corporation

·       Cerevast Therapeutics Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cortical Stimulators Pipeline Market Segmentation by Territories

Some of the key territories in the cortical stimulators market are the US, Europe, India, Japan, and Taiwan among others. As of May 2023, the US has the highest number of pipeline products.

Cortical Stimulators Pipeline Market Analysis, by Territories, 2023 (%)

Cortical Stimulators Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the cortical stimulators pipeline market, download a free report sample

Cortical Stimulators Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the cortical stimulators pipeline market are PMA, 510(k), CE, BOPA, TGA, ICAC, and NIFDS among others. As of May 2023, PMA is the most followed pathway for pipeline products.

Cortical Stimulators Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Cortical Stimulators Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the cortical stimulators pipeline market, download a free report sample

Cortical Stimulators Pipeline Market – Competitive Landscape

Some of the key companies in the cortical stimulators pipeline market are ab medica spa, Aleva Neurotherapeutics SA, Cadence Neuroscience Inc, Catalan Institute of Nanoscience and Nanotechnology, Cerephex Corporation, and Cerevast Therapeutics Inc among others.

ab medica spa: AB Medica SpA (AB Medica) is a medical technology company that offers robotic solutions. The company offers products such as surgical robotic products, nanotechnology products, and medical devices. It also provides insufflators, mini-invasive surgery products, baldness surgery products, orthopedic surgery products, spinal surgery products, and endoscopy and endovascular products, among others. The company partners with universities, research centers, and scientific laboratories. It has operations in Rome, Padova, and Fisciano, Italy. AB Medica is headquartered in Milan, Italy.

Segments Covered in the Report

Cortical Stimulators Pipeline Market Territories Outlook

  • The US
  • Europe
  • India
  • Japan
  • Taiwan

Cortical Stimulators Pipeline Market Regulatory Paths Outlook

  • PMA
  • 510(k)
  • CE
  • BOPA
  • TGA
  • ICAC
  • NIFDS

Scope

  • Extensive coverage of the cortical stimulators under development

  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities

  • Reviews the major players involved in the development of cortical stimulators and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of cortical stimulators under development

  • Develop market-entry and market-expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

ab medica spa
Aleva Neurotherapeutics SA
Cadence Neuroscience Inc
Catalan Institute of Nanoscience and Nanotechnology
Cerephex Corporation
Cerevast Therapeutics Inc
Cognito Therapeutics Inc
Cortivis
Iowa State University
King's College London
Koninklijke Philips NV
Lawrence Livermore National Laboratory
Neuronix Ltd
Nexstim Plc
NYU Langone Health System
Polytechnique Montreal
Precisis AG
Ripple
St. Jude Medical LLC
University of Wisconsin Madison
WISE s.r.l.

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Cortical Stimulators Overview

  • 3 Products under Development

    • 3.1 Cortical Stimulators – Pipeline Products by Stage of Development

    • 3.2 Cortical Stimulators – Pipeline Products by Territory

    • 3.3 Cortical Stimulators – Pipeline Products by Regulatory Path

    • 3.4 Cortical Stimulators – Pipeline Products by Estimated Approval Date

    • 3.5 Cortical Stimulators – Ongoing Clinical Trials

  • 4 Cortical Stimulators – Pipeline Products under Development by Companies

    • 4.1 Cortical Stimulators Companies – Pipeline Products by Stage of Development

    • 4.2 Cortical Stimulators – Pipeline Products by Stage of Development

  • 5 Cortical Stimulators Companies and Product Overview

    • 5.1 ab medica spa Company Overview

      • 5.1.1 ab medica spa Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Aleva Neurotherapeutics SA Company Overview

      • 5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Cadence Neuroscience Inc Company Overview

      • 5.3.1 Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Catalan Institute of Nanoscience and Nanotechnology Company Overview

      • 5.4.1 Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Cerephex Corporation Company Overview

      • 5.5.1 Cerephex Corporation Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Cerevast Therapeutics Inc Company Overview

      • 5.6.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Cognito Therapeutics Inc Company Overview

      • 5.7.1 Cognito Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Cortivis Company Overview

      • 5.8.1 Cortivis Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Iowa State University Company Overview

      • 5.9.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 King’s College London Company Overview

      • 5.10.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Koninklijke Philips NV Company Overview

      • 5.11.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Lawrence Livermore National Laboratory Company Overview

      • 5.12.1 Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Neuronix Ltd Company Overview

      • 5.13.1 Neuronix Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Nexstim Plc Company Overview

      • 5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 NYU Langone Health System Company Overview

      • 5.15.1 NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Polytechnique Montreal Company Overview

      • 5.16.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Precisis AG Company Overview

      • 5.17.1 Precisis AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Ripple Company Overview

      • 5.18.1 Ripple Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 St. Jude Medical LLC Company Overview

      • 5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 University of Wisconsin Madison Company Overview

      • 5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 WISE s.r.l. Company Overview

      • 5.21.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Cortical Stimulators- Recent Developments

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Cortical Stimulators – Pipeline Products by Stage of Development 9

Cortical Stimulators – Pipeline Products by Territory 10

Cortical Stimulators – Pipeline Products by Regulatory Path 11

Cortical Stimulators – Pipeline Products by Estimated Approval Date 12

Cortical Stimulators – Ongoing Clinical Trials 13

Cortical Stimulators Companies – Pipeline Products by Stage of Development 14

Cortical Stimulators – Pipeline Products by Stage of Development 15

ab medica spa Pipeline Products & Ongoing Clinical Trials Overview 16

Cyberbrain – Product Status 16

Cyberbrain – Product Description 16

Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 17

cortiSTIM – Product Status 17

cortiSTIM – Product Description 17

Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Next Generation Implantable Device – Epilepsy – Product Status 18

Next Generation Implantable Device – Epilepsy – Product Description 18

Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview 19

Neuroprosthetic Cortical Device – Product Status 19

Neuroprosthetic Cortical Device – Product Description 19

Cerephex Corporation Pipeline Products & Ongoing Clinical Trials Overview 20

NeuroPoint – Product Status 20

NeuroPoint – Product Description 20

Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Pulsed Transdermal Electrical Stimulation Device – Migraine – Product Status 21

Pulsed Transdermal Electrical Stimulation Device – Migraine – Product Description 21

Cognito Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 22

CogTx-001 – Product Status 22

CogTx-001 – Product Description 22

Cognito Therapeutics Inc – Ongoing Clinical Trials Overview 23

CogTx-001 – A Randomized, Double-blind, Sham-controlled, Adaptive- Design Pivotal Study of Sensory Stimulation in Subjects with Alzheimer’s Disease (Hope Study, CA-0011) 24

CogTx-001 – Multi-center Study of Sensory Stimulation to Improve Brain Function: Overture Study 24

CogTx-001 – Multi-Center Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) 24

CogTx-001 – Sensory-Evoked Cortical Gamma Oscillation: Impact on Visual Processing and Cognitive Function in Patients with Alzheimer’s Disease 25

Cortivis Pipeline Products & Ongoing Clinical Trials Overview 26

Cortical Visual Neuroprosthesis Implant – Product Status 26

Cortical Visual Neuroprosthesis Implant – Product Description 26

Cortivis – Ongoing Clinical Trials Overview 27

Cortical Visual Neuroprosthesis Implant – Pilot Study for the Development of a Cortical Visual Neuroprosthesis for the Blind Based on Intracortical Microelectrodes 28

Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 29

Quadruple Butterfly Coil – Product Status 29

Quadruple Butterfly Coil – Product Description 29

King’s College London Pipeline Products & Ongoing Clinical Trials Overview 30

rTMS System – Bulimia – Product Status 30

rTMS System – Bulimia – Product Description 30

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 31

GTEN 100 Neuromodulation Device – Product Status 31

GTEN 100 Neuromodulation Device – Product Description 32

Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 33

Implantable Neural Device – Product Status 33

Implantable Neural Device – Product Description 33

Neuronix Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

NeuroAD – Product Status 34

NeuroAD – Product Description 34

NeuroAD – MCI – Product Status 35

NeuroAD – MCI – Product Description 35

Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 36

Navigated Brain Therapy System – Major Depressive Disorder – Product Status 36

Navigated Brain Therapy System – Major Depressive Disorder – Product Description 37

Navigated Brain Therapy System – Tinnitus – Product Status 37

Navigated Brain Therapy System – Tinnitus – Product Description 37

Wireless EMG Integrated NBS System – Product Status 38

Wireless EMG Integrated NBS System – Product Description 38

Nexstim Plc – Ongoing Clinical Trials Overview 39

Navigated Brain Therapy System – Major Depressive Disorder – Use of Nexstim SNBT System in Its Intended Use 40

NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview 41

Brain Implant – Chronic Pain – Product Status 41

Brain Implant – Chronic Pain – Product Description 41

Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview 42

Microelectrode Array – Cortical Stimulation – Product Status 42

Microelectrode Array – Cortical Stimulation – Product Description 42

Precisis AG Pipeline Products & Ongoing Clinical Trials Overview 43

EASEE System – Product Status 43

EASEE System – Product Description 43

Precisis AG – Ongoing Clinical Trials Overview 44

EASEE System – EASEE4YOU – A Clinical Investigation of the Safety and Efficacy of Transcranial Focal Cortex Stimulation with the EASEE System for the Treatment of Medically Refractory Focal Epilepsy in Young Patients, Aged 12 to 17 Years 45

Ripple Pipeline Products & Ongoing Clinical Trials Overview 46

Wireless EcoG Device – Product Status 46

Wireless EcoG Device – Product Description 46

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 47

Renova-DT Cortical Stimulation System – Product Status 47

Renova-DT Cortical Stimulation System – Product Description 47

Renova-ST Cortical Stimulation System – Product Status 48

Renova-ST Cortical Stimulation System – Product Description 48

Renova-TT Cortical Stimulation System – Product Status 48

Renova-TT Cortical Stimulation System – Product Description 49

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 50

Brain-Computer Microelectrode Interface – Product Status 50

Brain-Computer Microelectrode Interface – Product Description 51

WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 52

Cortical Grid – Product Status 52

Cortical Grid – Product Description 52

Glossary 81

Figures

Cortical Stimulators – Pipeline Products by Stage of Development 9

Cortical Stimulators – Pipeline Products by Territory 10

Cortical Stimulators – Pipeline Products by Regulatory Path 11

Cortical Stimulators – Pipeline Products by Estimated Approval Date 12

Cortical Stimulators – Ongoing Clinical Trials 13

Frequently asked questions

Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cortical Stimulators reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more